HIV Surveillance Summary
Georgia, 2017
HIV/AIDS Epidemiology Section Epidemiology Program Division of Health Protection Georgia Department of Public Health

2017 Georgia HIV Surveillance Summary

Page 1

The HIV Surveillance Summary, Georgia 2017 is published by the Georgia Department of Public Health (DPH), HIV/AIDS Epidemiology Section (HAES), 2 Peachtree Street NW, Atlanta, Georgia 30303. Data are presented from known diagnoses and laboratory reports entered into the Georgia Enhanced HIV/AIDS Reporting System (eHARS). All data are provisional.
The HIV Surveillance Summary, Georgia 2017 is not copyrighted and may be used and reproduced without permission. Citation of the source is, however, appreciated.
SUGGESTED CITATION: Georgia Department of Public Health, HIV/AIDS Epidemiology Section HIV Surveillance Summary, Georgia 2017, https://dph.georgia.gov/data-fact-sheet-summaries, Published February 2019, [Accessed: date]
ACKNOWLEDGEMENTS: Publication of this report was made possible with the contributions of the Georgia DPH HAES Core HIV Surveillance staff, HIV Case Report Forms submitted by Georgia health care facility staff, HIV infection related laboratory test results transmitted by laboratory facilities in Georgia, data matches with other DPH programs, and the ongoing efforts of multiple individuals from public and private sector organizations dedicated to improving surveillance, prevention, testing, and care of persons living with HIV infection.
Georgia HIV Core Surveillance Team contributors: Lauren Barrineau-Vejjajiva, Thelma Fannin, Latosha Johnson, Rodriques Lambert, Mildred McGainey, Latoya Moss, Kim Norris, Rama Namballa, Doris Pearson, A. Eugene Pennisi, Akilah Spratling, Sylve Rawls, Emory Searcy, and Gerriana Willams.
This report was prepared by the following staff from the Georgia Department of Public Health: Wendy Wen, MPH; Pascale Wortley, MD, MPH; Cherie Drenzek, DVM, MS.

2017 Georgia HIV Surveillance Summary

Page 2

Table of Contents
INTRODUCTION ....................................................................................................................................................................... 5 TECHNICAL NOTES .................................................................................................................................................................. 6
Definitions ........................................................................................................................................................................... 7 References .......................................................................................................................................................................... 8 TABLES..................................................................................................................................................................................... 9 HIV Diagnoses and persons living with HIV, Georgia, 2017 .............................................................................................. 10
Table 1. HIV diagnoses, late diagnoses, and stage 3 (AIDS) diagnoses, Georgia, 2017 ................................................ 10 Table 2. HIV diagnoses, late diagnoses, and stage 3 (AIDS) diagnoses among males, Georgia, 2017.......................... 11 Table 3. HIV diagnoses, late diagnoses, and stage 3 (AIDS) diagnoses among females, Georgia, 2017 ...................... 12 Table 4. HIV diagnoses, late diagnoses, and stage 3 (AIDS) diagnoses among transgender persons, Georgia, 2017 .. 13 Table 5. Persons Living with HIV (PLWH), and PLWH ever Stage 3 (AIDS), Georgia, as of 12/31/2016 ....................... 14 Table 6. Persons living with HIV (PLWH), and PLWH ever stage 3 (AIDS), males, Georgia, as of 12/31/2016 ............. 15 Table 7. Persons Living with HIV (PLWH), and PLWH ever Stage 3 (AIDS), females, Georgia, as of 12/31/2017......... 16 Table 8. Persons Living with HIV (PLWH), and PLWH ever Stage 3 (AIDS), transgender persons, Georgia, as of 12/31/2017 ................................................................................................................................................................... 17 HIV Diagnoses and Persons Living with HIV by Public Health District .............................................................................. 18 Table 9. HIV Diagnoses and Persons Living with HIV, District 1-1 (Rome), Georgia, 2017 ........................................... 18 Table 10. HIV Diagnoses and Persons Living with HIV, District 1-2 (Dalton), Georgia, 2017........................................ 19 Table 11. HIV Diagnoses and Persons Living with HIV, District 2 (Gainesville), Georgia, 2017 .................................... 20 Table 12 HIV Diagnoses and Persons Living with HIV, District 3-1 (Cobb-Douglas), Georgia, 2017 ............................. 21 Table 13. HIV Diagnoses and Persons Living with HIV, District 3-2 (Fulton), Georgia, 2017 ........................................ 22 Table 14. HIV Diagnoses and Persons Living with HIV, District 3-3 (Clayton), Georgia, 2017 ...................................... 23 Table 15. HIV Diagnoses and Persons Living with HIV, District 3-4 (East Metro), Georgia, 2017................................. 24 Table 16. HIV Diagnoses and Persons Living with HIV, District 3-5 (DeKalb), Georgia, 2017 ....................................... 25 Table 17. HIV Diagnoses and Persons Living with HIV, District 4 (LaGrange), Georgia, 2017....................................... 26 Table 18. HIV Diagnoses and Persons Living with HIV, District 5-1 (Dublin), Georgia, 2017 ........................................ 27 Table 19. HIV Diagnoses and Persons Living with HIV, District 5-2 (Macon), Georgia, 2017 ....................................... 28 Table 20. HIV Diagnoses and Persons Living with HIV, District 6 (Augusta), Georgia, 2017......................................... 29 Table 21. HIV Diagnoses and Persons Living with HIV, District 7 Columbus), Georgia, 2017 ....................................... 30 Table 22. HIV Diagnoses and Persons Living with HIV, District 8-1 (Valdosta), Georgia, 2017..................................... 31 Table 23. HIV Diagnoses and Persons Living with HIV, District 8-2 (Albany), Georgia, 2017........................................ 32

2017 Georgia HIV Surveillance Summary

Page 3

Table 24. HIV Diagnoses and Persons Living with HIV, District 9-1 (Savannah), Georgia, 2017 ................................... 33 Table 25. HIV Diagnoses and Persons Living with HIV, District 9-2 (Waycross), Georgia, 2017 ................................... 34 Table 26. HIV Diagnoses and Persons Living with HIV, District 10 (Athens), Georgia, 2017 ........................................ 35 HIV Diagnoses and Persons Living with HIV, Atlanta MSA.............................................................................................. 366 Table 27. HIV Diagnoses and Persons Living with HIV, Atlanta Metropolitan Statistical Area1, Georgia, 2017 ........... 36 Late Diagnoses by Public Health District and Atlanta MSA .............................................................................................. 37 Table 28. Late diagnoses by Public Health District and for Atlanta Metropolitan Statistical Area, Georgia, 2017 ...... 37 Public Health District and County Rates ........................................................................................................................... 38 Table 29. HIV diagnoses and persons living with HIV (PLWH): Public Health District and County number and rates per 100,000 population, Georgia 2017 ......................................................................................................................... 38 Distribution of General Population by Race/Ethnicity...................................................................................................... 43 Table 30. Distribution of the general population by race/ethnicity, Georgia 2016...................................................... 43 HIV/AIDS RESOURCES: .......................................................................................................................................................... 44

2017 Georgia HIV Surveillance Summary

Page 4

INTRODUCTION
HIV infection remains an important public health problem in the state of Georgia. As of the end of 2017, there were 58,808 persons living with HIV in Georgia, and 2,698 persons were diagnosed in 2017. The number of persons living with HIV continues to increase, because of effective therapies now available. Based on the Centers for Disease Control and Prevention's 2017 HIV Surveillance Report, Georgia was ranked the fifth highest in the nation for both the total number of new diagnoses of HIV infection among adults and adolescents and for the number of persons living with HIV infection, after Florida, California, Texas, and New York1. Georgia ranked 1st in the rate of HIV diagnosis among adults and adolescents, and 4th in the rate of persons living with HIV.
Monitoring the HIV/AIDS epidemic and understanding the burden of HIV infection in Georgia are essential for meeting the goals stated in the 2020 National HIV/AIDS Strategy to: 1) reduce HIV infections; 2) increase access to care and optimize health outcomes for persons living with HIV; 3) reduce HIV-related health disparities, and; 4) achieve a more coordinated national response to the HIV epidemic.

Information on the Georgia HIV care continuum can be found in a separate report at the following web page: https://dph.georgia.gov/hiv-care-continuum.

2017 Georgia HIV Surveillance Summary

Page 5

TECHNICAL NOTES
Georgia statutes and regulations (O.C.G.A. 3112-2(b)) require healthcare providers (such as nurses, nurse practitioners, doctors, physician assistants) licensed in the state of Georgia to report all cases of HIV infection and/or Stage 3 (AIDS) to the Georgia DPH within seven days of diagnosis2. Laboratories licensed in the state of Georgia are required to report all HIV-related laboratory test results within 7 days. The information is used to monitor the HIV/AIDS epidemic in Georgia and guide program planning and evaluation. The data presented in the accompanying tables are based on confidential case reports collected through the Georgia DPH enhanced HIV/AIDS Reporting System (eHARS).
AIDS reporting began in the early 1980s, and HIV reporting began in Georgia on December 31, 2003. Electronic transmission of laboratory test results began in 2011. Receipt of CD4 counts and viral load tests make it possible to estimate the HIV Care Continuum for persons with a diagnosis of HIV infection in the state of Georgia (reports are available at: https://dph.georgia.gov/hiv-carecontinuum).

HIV diagnoses include persons with a diagnosis of HIV infection, regardless of the stage of disease at diagnosis, who were residents of Georgia at the time of diagnosis. Persons living with HIV are those with a residence in the state of Georgia, based on current information available in the Georgia HIV/AIDS surveillance system, regardless of where they resided at the time of diagnosis. Persons residing in correctional facilities are included in this report and may inflate rates in certain geographic regions where there are large numbers of HIV-positive inmates.
Information on transmission category is missing for 30% of cases. Multiple imputation, a statistical approach, is used to replace each missing transmission category with a set of plausible values that represent the uncertainty about the true, but missing, value3. The methods were applied to adult and adolescent, but not pediatric cases. Multiple imputation is considered by the Centers for Disease Control and Prevention to be the best method for redistribution of missing data in large databases. Transmission category is shown with missing data, and after multiple imputation. Cases missing race/ethnicity are not assigned a risk through multiple imputation.

This report includes surveillance data reported through December 31, 2017 for cases diagnosed through December 31, 2016. This report is limited to cases diagnosed through December 2016 to take into account delays in reporting, and to allow for obtaining follow up information on reported cases.

Persons for whom the current identity box "transgender" was checked on the case report form are classified as transgender. Because providers often do not complete all case report forms fields, the numbers reported here are most likely an underestimate. Additionally, because the current identity fields were

2017 Georgia HIV Surveillance Summary

Page 6

added to the case report form in 2007, prevalent counts of HIV among transgender persons are incomplete.
For data presented at the Public Health District or MSA level, all cells <5 observations are censored in accordance with the Georgia Department of Public Health HIV Surveillance Security and Confidentiality Guidelines.
Definitions
HIV DIAGNOSES are cases diagnosed between January 1 and December 31, 2017, with an address at the time of HIV diagnosis was in Georgia, and who were reported to the Georgia Department of Public Health by December 31 2018, regardless of stage at diagnosis. This group includes persons whose initial diagnosis is Stage 3 (AIDS).
LATE DIAGNOSES are the subset of HIV diagnoses who are found to be Stage 3 (AIDS) within 12 months of HIV diagnosis date. Such persons are termed late diagnoses because their advanced stage at diagnosis indicates that they were most likely infected for many years before diagnosis. STAGE 3 (AIDS) DIAGNOSES include two groups: 1) persons newly diagnosed with HIV in 2017, found to
meet the definition for Stage 3 (AIDS) at diagnosis, and with an address at or near the time of Stage 3 diagnosis in Georgia; and, 2) persons found to meet the Stage 3 definition in 2017 with an address at or near the time of Stage 3 diagnosis in Georgia, regardless of the date of their initial HIV diagnosis.

PERSONS LIVING WITH HIV INFECTION are persons diagnosed by December 31, 2017, who are not known to be deceased, and for whom the most recent address available is in Georgia.
PERSONS LIVING WITH HIV, EVER STAGE 3 are persons diagnosed by December 31, 2017, who are not known to be deceased, for whom the most recent address available is in Georgia, and who met the case definition for Stage 3 (AIDS) at some point.
TRANSMISSION CATEGORIES presented in this report follow the standards created by the Centers for Disease Control and Prevention (CDC) and have been used for many years. According to the CDC, transmission category is the term for the classification of cases that summarizes a person's possible HIV risk factors. The summary classification results from selecting the one most likely risk factor to have been responsible for HIV transmission from the presumed hierarchical order of probability. For surveillance purposes, HIV and AIDS cases are counted only once in the hierarchy of transmission categories. Persons with more than one reported risk factor for HIV infection are classified in the transmission category according to the behavior that is most likely to have resulted in transmission. The exception is men who report sexual contact with other men and injection drug use; this group makes up a separate transmission category. Persons whose transmission category is classified as heterosexual contact are persons who report heterosexual contact specifically with a person known to have or be at high risk for HIV infection (e.g., an injection drug user/IDU).

2017 Georgia HIV Surveillance Summary

Page 7

The term high risk is not included in the transmission category label for heterosexual contact in the tables because heterosexual contact itself is the risk factor most likely to have been responsible for transmission. However, the Table 3 footnote regarding this category clarifies how the data are defined: "heterosexual contact with a person known to have, or to be at high risk for, HIV infection".
CURRENT RESIDENCE Current address is determined using the date of the most recently-entered residential address as of 12/31/2017 into the Georgia eHARS. The number of persons living with HIV is based on current address.

presented for case numbers less than 12 because these rates have relative standard errors greater than 30% and are considered unreliable.
PERCENTAGES: Total percentages may not add up to 100% due to rounding.
COUNTS: Counts in the gender, race/ethnicity, and age categories may not add up to the overall totals due to a small number of cases with missing information (<2 percent).
References

VITAL STATUS: Persons are assumed to be alive unless otherwise documented or reported. The Georgia DPH performs an annual match of the eHARS database with the Georgia Vital Records death data, the National Death Index and the Social Security Death Index to ascertain vital status.
RATES: Denominators for population rates are based on the 2017 estimates of the Georgia resident population retrieved from the Georgia Department of Public Health, Office of Health Indicators for Planning (OHIP). Rates are per 100,000 population. Rates are not

1. Centers for Disease Control and Prevention. HIV Surveillance Report, 2017; vol.29. https://www.cdc.gov/hiv/pdf/library/reports/surveillance/ cdc-hiv-surveillance-report-2016-vol-29.pdf 2. Department of Public Health, Rules and regulations 290-48.11 (2003); Official Code of Georgia Annotated (O.C.G.A.) 31-22-9.2 (2011)
3. Harrison KM, Kajese T, Hall HI, Song R. Risk factor redistribution of the national HIV/AIDS surveillance data: an alternative approach. Public Health Rep 2008;123:61827.

2017 Georgia HIV Surveillance Summary

Page 8

TABLES

2017 Georgia HIV Surveillance Summary

Page 9

HIV Diagnoses and persons living with HIV, Georgia, 2017

Table 1. HIV diagnoses, late diagnoses, and stage 3 (AIDS) diagnoses, Georgia, 2017

HIV Diagnoses (all stages)

Late HIV Diagnoses1

N

%*

N

%* row %

Total

2,698

613

Gender Identity

Male

2,089

77.3

472

77.0

22.6

Female

587

21.7

138

22.5

23.5

Transgender

22

0.8

3

0.3

13.6

Race/Ethnicity
Black/Non Hispanic

1,908

70.6

425

69.3

22.3

White/Non Hispanic

443

16.4

102

16.6

23.0

Hispanic/Latino, Any Race

199

7.4

58

9.5

29.1

American Indian/Alaska Native

2

0.1

0

0.0

0.0

Asian/Native Hawaiian/Pacific Islander

27

1.0

8

1.3

29.6

Multiple races

62

2.3

13

2.1

21.0

Age Group at Diagnosis (Years)
<13

7

0.3

3

0.5

42.9

13-19

141

5.2

18

2.9

12.8

20-29

1,049

38.8

149

24.3

14.2

30-39

672

24.9

153

25.0

22.8

40-49

401

14.8

138

22.5

34.4

50-59

304

11.3

108

17.6

35.5

60+

127

4.7

44

7.2

34.6

Transmission Category (Unadjusted)
Male-to-male sexual contact (MSM)

1,462

54.1

289

47.1

19.8

Injection drug use (IDU)

52

1.9

16

2.6

30.8

MSM-IDU

29

1.1

7

1.1

24.1

Heterosexual contact3

517

19.1

155

25.3

30.0

Perinatal/other pediatric4

7

0.2

3

0.3

42.9

Unknown

636

23.5

143

23.5

22.5

Transmission Category (Adjusted)5
MSM-IDU

1,734

64.2

346

56.5

20.0

IDU

83

3.1

26

4.2

31.3

MSM-IDU Heterosexual contact3

38

1.4

773

28.6

9

1.5

23.7

223

36.4

28.8

Perinatal/other pediatric4

7

0.2

3

0.3

42.9

Stage 3 (AIDS) Diagnoses2

N

%*

1,152

857

74.4

281

24.4

14

1.0

841

73.0

186

16.1

79

6.9

0

0.0

11

1.0

34

3.0

6

0.5

18

1.6

269

23.4

299

26.0

260

22.6

210

18.2

90

7.8

558

48.4

35

3.0

24

2.1

239

20.7

6

0.5

290

25.2

673

58.4

60

5.2

31

2.6

379

32.9

6

0.5

*Percentages may not add up to 100% due to rounding. 1. Late diagnosis: stage 3 (AIDS) diagnosis within 12 months of HIV diagnosis. Row % is percent of HIV diagnoses that were late diagnoses 2. Stage 3 (AIDS): includes persons diagnosed with stage 3 in 2016, regardless of year of HIV diagnosis. 3. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with. hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 4. Perinatal/other pediatric: cases born to HIV-infected mother, cases <13 with missing risk, and cases <13 with other risk (e.g. sexual transmission). 5. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding.

2017 Georgia HIV Surveillance Summary

Page 10

Table 2. HIV diagnoses, late diagnoses, and stage 3 (AIDS) diagnoses among males, Georgia, 2017

HIV Diagnoses (all stages)

Late HIV Diagnoses1

Stage 3 (AIDS) Diagnoses2

Total Race/Ethnicity
Black/Non Hispanic

N

%*

N

%* row %

N

2,085

100.0

471

100.0

22.6

857

1,429

68.5

309

65.6

21.6

604

%*
100.0
70.5

White/Non Hispanic

369

17.7

82

17.4

22.2

148

17.3

Hispanic/Latino, Any Race

168

8.1

53

11.3

31.5

65

7.6

American Indian/Alaska Native

2

0.1

0

0.0

0.0

0

0.0

Asian/Native Hawaiian/Pacific Islander

23

1.1

7

1.5

30.4

10

1.2

Multiple races

53

2.5

13

2.8

24.5

29

3.4

Age Group at Diagnosis (Years)
<13

4

0.2

3

0.6

75.0

6

0.7

13-19

114

5.5

16

3.4

14.0

15

1.8

20-29

888

42.6

126

26.8

14.2

222

25.9

30-39

513

24.6

122

25.9

23.8

236

27.5

40-49

279

13.4

99

21.0

35.5

173

20.2

50-59

207

9.9

75

15.9

36.2

151

17.6

60+

80

3.8

30

6.4

37.5

54

6.3

Transmission Category (Unadjusted)
Male-to-male sexual contact (MSM)

1,440

69.1

287

60.9

19.9

545

63.6

Injection drug use (IDU)

29

1.4

5

1.1

17.2

20

2.3

MSM-IDU Heterosexual contact3 Perinatal/other pediatric4

29

1.4

7

1.5

24.1

24

2.8

203

9.7

85

18.0

41.9

104

12.1

4

0.1

3

0.4

75.0

6

0.7

Unknown

380

18.3

84

18.0

22.1

158

18.4

Transmission Category (Adjusted) MSM

1,715

82.3

344

73.1

20.1

660

77.0

IDU

44

2.1

9

1.9

20.5

30

3.5

MSM-IDU Heterosexual contact3 Perinatal/other pediatric4

38

1.8

9

2.0

23.7

31

3.6

244

11.7

99

21.1

40.6

128

14.9

4

0.1

3

0.4

75.0

6

0.7

* Percentages may not add up to 100% due to rounding. 1. Late diagnosis: stage 3 (AIDS) diagnosis within 12 months of HIV diagnosis. Row % is percent of HIV diagnoses that were late diagnoses 2. Stage 3 (AIDS): includes persons diagnosed with stage 3 in 2016, regardless of year of HIV diagnosis. 3. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with. hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 4. Perinatal/other pediatric: cases born to HIV-infected mother, cases <13 with missing risk, and cases <13 with other risk (e.g. sexual transmission). 5. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding.

2017 Georgia HIV Surveillance Summary

Page 11

Table 3. HIV diagnoses, late diagnoses, and stage 3 (AIDS) diagnoses among females, Georgia, 2017

HIV Diagnoses (all stages)

Late HIV Diagnoses1

Stage 3 (AIDS) Diagnoses2

Total Race/Ethnicity
Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race Asian/Native Hawaiian/Pacific Islander Multiple races
Age Group at Diagnosis (Years)
<13 13-19 20-29 30-39 40-49 50-59 60+
Transmission Category (Unadjusted)
Injection drug use Heterosexual contact3 Perinatal/other pediatric4 Unknown
Transmission Category (Adjusted)
Injection drug use Heterosexual contact3 Perinatal/other pediatric4

N

%*

N

%* row %

N

587

100.0

138

100.0

23.5

281

457

77.9

113

81.9

24.7

224

72

12.3

20

14.5

27.8

38

28

4.8

4

2.9

14.3

13

4

0.7

1

0.7

25.0

1

9

1.5

0

0.0

0.0

5

3

0.5

0

0.0

0.0

0

26

4.4

2

1.4

7.7

3

143

24.4

21

15.2

14.6

37

153

26.1

30

21.7

21.0

62

120

20.4

38

27.5

31.7

85

95

16.2

33

23.9

35.7

58

47

8.0

14

10.1

29.7

36

22

3.7

314

53.5

3

0.3

247

42.2

9

6.5

40.9

14

69

50.0

22.0

135

0

1.5

66.0

0

60

43.5

24.3

134

38

6.5

14

10.5

36.8

29

528

90.0

124

89.5

23.5

251

3

0.3

0

1

%*
100.0
79.7 13.5
4.6 0.4 1.8
0.0 1.4 13.2 22.1 30.2 20.7 12.8
5.0 48.0
1.0 47.0
10.2 89.4

* Percentages may not add up to 100% due to rounding. 1. Late diagnosis: stage 3 (AIDS) diagnosis within 12 months of HIV diagnosis. Row % is percent of HIV diagnoses that were late diagnoses 2. Stage 3 (AIDS): includes persons diagnosed with stage 3 in 2016, regardless of year of HIV diagnosis. 3. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with. hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 4. Perinatal/other pediatric: cases born to HIV-infected mother, cases <13 with missing risk, and cases <13 with other risk (e.g. sexual transmission). 5. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding.

2017 Georgia HIV Surveillance Summary

Page 12

Table 4. HIV diagnoses, late diagnoses, and stage 3 (AIDS) diagnoses among transgender persons, Georgia, 2017

HIV Diagnoses (all stages)

Late HIV Diagnoses1

Stage 3 (AIDS) Diagnoses2

Total Gender Identity
Transgender Male-to-Female Transgender Unknown
Race/Ethnicity
Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race
Age Group at Diagnosis (Years)
13-19 20-29 30-39 40-49 50-59
Transmission Category (Unadjusted)
Sexual transmissson3 Injection drug use Sexual contact and injection drug use Unknown
Transmission Category (Adjusted)4
Sexual transmissson3 Injection drug use Sexual contact and injection drug use Unknown

N

%*

N

%*

row

N

%*

%

21

95.5

2

66.7

9.5

12

85.7

1

4.5

1

33.3

100.0

2

14.3

19

86.4

2

66.7

10.5

13

92.9

2

9.1

0

0.0

0.0

0

0.0

1

4.5

1

33.3

100.0

1

7.1

1

4.5

0

0.0

0.0

0

0.0

13

59.1

2

66.7

15.4

11

78.6

5

22.7

0

0.0

0.0

1

7.1

1

4.5

0

0.0

0.0

1

7.1

2

9.1

1

33.3

50.0

1

7.1

20

90.9

2

66.7

10.0

13

92.9

1

4.5

1

33.3

100.0

1

7.1

0

0

0.0

0.0

0

0.0

1

4.5

0

0.0

0.0

0

0.0

21

95.5

2

66.7

9.5

13

92.9

1

4.5

1

33.3

100.0

1

7.1

0

0.0

0

0.0

0.0

0

0.0

1. Late diagnosis: stage 3 (AIDS) diagnosis within 12 months of HIV diagnosis. 2. Stage 3 (AIDS): includes persons diagnosed with stage 3 in 2016, regardless of year of HIV diagnosis. 3. Includes sex with male and probable heterosexual transmission as noted in medical chart. 4. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding.

2017 Georgia HIV Surveillance Summary

Page 13

Table 5. Persons Living with HIV (PLWH), and PLWH ever Stage 3 (AIDS), Georgia, as of 12/31/2016

PLWH

Ever Stage 3 (AIDS)1

N

%*

N

%*

Total

58,808

30,719

Gender Identity

Male

44,350

75.4 23,240

75.7

Female

13,879

23.6 7,201

23.4

Transgender

509

0.9

259

0.8

Race/Ethnicity
Black/Non Hispanic

40,105

68.2 21,235

69.1

White/Non Hispanic

11,178

19.0 5,805

18.9

Hispanic/Latino, Any Race

3,816

6.5 2,012

6.6

American Indian/Alaska Native

30

0.1

10

0.0

Asian/Native Hawaiian/Pacific Islander

279

0.5

110

0.4

Multiple races

2,388

4.1 1,358

4.4

Current Age Group (Years)
<13

101

0.2

24

0.1

13-19

347

0.6

55

0.2

20-29

7,496

12.7 2,014

6.6

30-39

12,666

21.5 5,278

17.2

40-49

13,880

23.6 7,801

25.4

50-59

16,343

27.8 10,406

33.9

60+

7,962

13.5 5,138

16.7

Transmission Category (Unadjusted)

Male-to-male sexual contact (MSM)

28,476

48.4 14,661

47.7

Injection drug use (IDU)

2,534

4.3 1,781

5.8

MSM-IDU

1,900

3.2 1,267

4.1

Heterosexual contactt2

9,299

15.8 5,324

17.3

Adult Other3

565

1.0

297

1.0

Perinatal/other pediatric4

101

0.2

24

0.1

Unknown

15,933

27.1 7,365

24.0

Transmission Category (Adjusted)5

MSM-IDU

35,885

61.0 18,068

58.8

IDU

3,745

6.4 2,475

8.1

MSM-IDU

2,358

4.0 1,518

4.9

Heterosexual contactt2

15,143

25.7 8,144

26.5

Adult Other3

565

1.0

297

1.0

Perinatal/other pediatric4

101

0.2

24

0.1

* Percentages may not add up to 100% due to rounding. 1. Persons whose infection was ever classified as stage 3 (AIDS). 2. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 3. Adjusted for missing risk using multiple imputation methods. 4. Perinatal/other pediatric: cases born to HIV-infected mother, and cases <13 with missing risk. 5. Includes perinatal exposure, hemophilia, blood transfusion.

2017 Georgia HIV Surveillance Summary

Page 14

Table 6. Persons living with HIV (PLWH), and PLWH ever stage 3 (AIDS), males, Georgia, as of 12/31/2016

PLWH

Ever Stage 3 (AIDS)1

Total Race/Ethnicity
Black/Non Hispanic

N
44,350
28,933

%*
100.0
65.2

N
23,240
15,298

%*
100.0
65.8

White/Non Hispanic

9,612

21.7

5,066

21.8

Hispanic/Latino, Any Race

3,017

6.8

1,611

6.9

American Indian/Alaska Native

23

0.1

7

0.0

Asian/Native Hawaiian/Pacific Islander

216

0.5

87

0.4

Multiple races

1,817

4.1

1,027

4.4

Current Age Group (Years)

<13

49

0.1

14

0.1

13-19

219

0.5

35

0.2

20-29

6,311

14.2

1,668

7.2

30-39

9,787

22.1

4,112

17.7

40-49

9,933

22.4

5,594

24.1

50-59

12,317

27.8

7,998

34.4

60+

5,726

12.9

3,817

16.4

Transmission Category (Unadjusted)
Male-to-male sexual contact (MSM)

28,069

63.3

14,464

62.2

Injection drug use (IDU)

1,467

3.3

1,073

4.6

MSM-IDU

1,880

4.2

1,257

5.4

Heterosexual contactt2

2,413

5.4

1,514

6.5

Adult Other3

277

0.6

149

0.6

Perinatal/other pediatric4

49

0.1

14

0.1

Unknown

10,197

23.0

4,769

20.5

Transmission Category (Adjusted)5
MSM

35,468

80.0

17,865

76.9

IDU

2,050

4.6

1,420

6.1

MSM-IDU

2,337

5.3

1,507

6.5

Heterosexual contactt2

3,451

7.8

2,145

9.2

Adult Other3

277

0.6

149

0.6

Perinatal/other pediatric4

49

0.1

14

0.1

* Percentages may not add up to 100% due to rounding. 1. Persons whose infection was ever classified as stage 3 (AIDS). 2. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 3. Adjusted for missing risk using multiple imputation methods. 4. Perinatal/other pediatric: cases born to HIV-infected mother, and cases <13 with missing risk. 5. Includes perinatal exposure, hemophilia, blood transfusion.

2017 Georgia HIV Surveillance Summary

Page 15

Table 7. Persons Living with HIV (PLWH), and PLWH ever Stage 3 (AIDS), females, Georgia, as of 12/31/2017

PLWH

Ever Stage 3 (AIDS)1

Total Race/Ethnicity
Black/Non Hispanic

N
13,879
10,737

%*
100.0
77.4

N
7,201
5,727

%*
100.0
79.5

White/Non Hispanic

1,541

11.1

726

10.1

Hispanic/Latino, Any Race

754

5.4

373

5.2

American Indian/Alaska Native

6

0.0

2

0.0

Asian/Native Hawaiian/Pacific Islander

61

0.4

22

0.3

Multiple races

552

4.0

318

4.4

Current Age Group (Years)
<13

51

0.4

9

0.1

13-19

125

0.9

20

0.3

20-29

1,053

7.6

307

4.3

30-39

2,681

19.3

1,077

15.0

40-49

3,805

27.4

2,123

29.5

50-59

3,943

28.4

2,358

32.7

60+

2,216

16.0

1,306

18.1

Transmission Category (Unadjusted)
Injection drug use

1,061

7.6

705

9.8

Heterosexual contactt2

6,860

49.4

3,793

52.7

Adult Other3

285

2.1

146

2.0

Perinatal/other pediatric4

51

0.3

9

0.1

Unknown

5,622

40.6

2,548

35.4

Transmission Category (Adjusted)5
Injection drug use

1,684

12.1

1,049

14.6

Heterosexual contact

11,633

83.8

5,963

82.8

Adult Other3

285

2.1

146

2.0

Perinatal/other pediatric4

51

0.3

9

0.1

* Percentages may not add up to 100% due to rounding. 1. Persons whose infection was ever classified as stage 3 (AIDS). 2. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 3. Adjusted for missing risk using multiple imputation methods. 4. Perinatal/other pediatric: cases born to HIV-infected mother, and cases <13 with missing risk. 5. Includes perinatal exposure, hemophilia, blood transfusion.

2017 Georgia HIV Surveillance Summary

Page 16

Table 8. Persons Living with HIV (PLWH), and PLWH ever Stage 3 (AIDS), transgender persons, Georgia, as of

12/31/2017

PLWH

Ever Stage 3 (AIDS)1

Total Gender Identity
Transgender Male-to-Female

N

%*

N

%*

471

92.5

238

91.9

Transgender Female-to-Male

33

6.5

18

7.0

Unknown

5

1.0

3

1.2

Race/Ethnicity
Black/Non Hispanic

423

83.1

206

79.5

White/Non Hispanic

22

4.3

11

4.2

Hispanic/Latino, Any Race

42

8.3

27

10.4

American Indian/Alaska Native

1

0.2

1

0.4

Asian/Native Hawaiian/Pacific Islander

2

0.4

1

0.4

Multiple races

19

3.7

13

5.0

Current Age Group (Years)
13-19 20-29

3

0.6

0.0

0

128

25.1

39

15.1

30-39

182

35.8

84

32.4

40-49

115

22.6

78

30.1

50-59

64

12.6

44

17.0

60+

16

3.1

13

5.0

Transmission Category (Unadjusted)

Sexual transmissson2

433

80.0

214

76.1

Injection drug use

4

0.8

2

0.8

Sexual contact and injection drug use

20

3.9

10

3.9

Adult other

3

0.6

2

0.8

Unknown

48

9.4

30

11.6

Transmission Category (Adjusted)3

Sexual transmissson2

476

81.9

240

78.4

Injection drug use

8

1.6

5

1.9

Sexual contact and injection drug use

21

4.1

11

4.1

Adult other

3

0.6

2

0.8

* Percentages may not add up to 100% due to rounding. 1. Persons whose infection was ever classified as stage 3 (AIDS). 2.Includes sex with male and probable heterosexual transmission as noted in medical chart 3. Adjusted for missing risk using multiple imputation methods

2017 Georgia HIV Surveillance Summary

Page 17

HIV Diagnoses and Persons Living with HIV by Public Health District

Table 9. HIV Diagnoses and Persons Living with HIV, District 1-1 (Rome), Georgia, 2017

Characteristics

HIV diagnoses

PLWH as of 12/31/2017

Total Gender Identity
Male

N

%

N

%

51

100 1,089

100

39

76.5

802

73.6

Female

11

21.6

284

26.1

Transgender

<5

--

<5

--

Race/Ethnicity
Black/Non Hispanic

16

31.4

404

37.1

White/Non Hispanic

31

60.8

533

48.9

Hispanic/Latino, Any Race

<5

--

82

7.5

Asian/Native Hawaiian/Pacific Islander

0

0.0

<5

0.4

Multiple races

0

0.0

45

4.1

Age Group at Diagnosis (Years)
<13

0

0.0

<5

--

13-19

0

0.0

5

0.5

20-29

16

31.4

94

8.6

30-39

7

13.7

193

17.7

40-49

15

29.4

282

25.9

50-59

11

21.6

318

29.2

60+

<5

--

193

17.7

Transmission Category (Unadjusted)
Male-to-male sexual contact (MSM)

25

49.0

447

41.0

Injection drug use (IDU)

<5

--

90

8.3

MSM-IDU

<5

--

45

4.1

Heterosexual contact1

8

15.7

154

14.1

Adult Other2

0

0.0

18

1.7

Perinatal/other pediatric3

0

0.0

<5

0.4

Unknown

15

29.4

331

30.4

Transmission Category (Adjusted)5
MSM

31

61.2

606

55.6

IDU

<5

--

114

10.5

MSM-IDU

<5

--

55

5.1

Heterosexual contact1

15

28.8

271

24.9

Adult Other2

0

0.0

18

1.7

Perinatal/other pediatric3

0

0.0

<5

0.4

* Percentages may not add up to 100% due to rounding 1. Includes Asian, Pacific Islander, Native Hawaiian, American Indian, Alaska Native, Multiple races 2. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 3. Includes perinatal exposure, hemophilia, blood transfusion.4. Perinatal/other pediatric: cases born to HIV-infected mother, and cases <13 with missing risk. 5. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding

2017 Georgia HIV Surveillance Summary

Page 18

Table 10. HIV Diagnoses and Persons Living with HIV, District 1-2 (Dalton), Georgia, 2017

Total Gender Identity
Male Female Transgender
Race/Ethnicity
Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race Asian/Native Hawaiian/Pacific Islander Multiple races Unknown
Age Group at Diagnosis (Years)
13-19 20-29 30-39 40-49 50-59 60+
Transmission Category (Unadjusted)
Male-to-male sexual contact (MSM) Injection drug use (IDU) MSM-IDU Heterosexual contact1 Adult Other2 Unknown
Transmission Category (Adjusted)5
MSM IDU MSM-IDU Heterosexual contact1 Adult Other2 Unknown

HIV diagnoses

N

%

28

100

PLWH as of 12/31/2017

N

%

677

100

23

82.1

539

79.6

<5

--

133

19.6

0

0.0

<5

--

5

17.9

131

19.4

14

50.0

387

57.2

6

21.4

106

15.7

<5

--

<5

--

<5

--

34

5.0

<5

--

16

2.4

<5

--

5

0.7

11

39.3

74

10.9

9

32.1

128

18.9

5

17.9

168

24.8

<5

--

198

29.2

0

0.0

104

15.4

18

64.3

351

51.8

<5

--

29

4.3

<5

--

34

5.0

<5

--

82

12.1

0

0.0

6

0.9

<5

--

175

25.8

18

64.3

430

63.5

<5

--

43

6.3

<5

--

41

6.1

5

18.9

141

20.8

0

0.0

6

0.9

<5

--

16

2.4

* Percentages may not add up to 100% due to rounding 1. Includes Asian, Pacific Islander, Native Hawaiian, American Indian, Alaska Native, Multiple races 2. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 3. Includes perinatal exposure, hemophilia, blood transfusion.4. Perinatal/other pediatric: cases born to HIV-infected mother, and cases <13 with missing risk. 5. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding

2017 Georgia HIV Surveillance Summary

Page 19

Table 11. HIV Diagnoses and Persons Living with HIV, District 2 (Gainesville), Georgia, 2017

HIV Diagnoses

PLWH as of 12/31/2017

Total Gender Identity
Male

N

%

N

%

40

100

829

100

28

70.0

591

71.3

Female

12

30.0

231

27.9

Transgender

0

0.0

5

0.6

Race/Ethnicity
Black/Non Hispanic

12

30.0

209

25.2

White/Non Hispanic

17

42.5

410

49.5

Hispanic/Latino, Any Race

9

22.5

129

15.6

American Indian/Alaska Native

0

0.0

<5

--

Asian/Native Hawaiian/Pacific Islander

<5

--

16

1.9

Multiple races

<5

--

36

4.3

Age Group at Diagnosis (Years)
<13

0

0.0

<5

--

13-19

7

17.5

9

1.1

20-29

11

27.5

85

10.3

30-39

7

17.5

154

18.6

40-49

10

25.0

218

26.3

50-59

<5

--

236

28.5

60+

<5

--

125

15.1

Transmission Category (Unadjusted)
Male-to-male sexual contact (MSM)

20

50.0

341

41.1

Injection drug use (IDU)

<5

--

44

5.3

MSM-IDU

<5

--

39

4.7

Heterosexual contact1

<5

--

115

13.9

Adult Other2

0

0.0

10

1.2

Perinatal/other pediatric3

0

0.0

<5

--

Unknown

12

30.0

278

33.7

Transmission Category (Adjusted)5
MSM

23

56.8

464

56.0

IDU

<5

--

66

7.9

MSM-IDU

<5

--

46

5.6

Heterosexual contact1

12

30.5

215

25.9

Adult Other2

0

0.0

10

1.2

Perinatal/other pediatric3

0

0.0

<5

--

* Percentages may not add up to 100% due to rounding 1. Includes Asian, Pacific Islander, Native Hawaiian, American Indian, Alaska Native, Multiple races 2. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 3. Includes perinatal exposure, hemophilia, blood transfusion.4. Perinatal/other pediatric: cases born to HIV-infected mother, and cases <13 with missing risk. 5. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding

2017 Georgia HIV Surveillance Summary

Page 20

Table 12. HIV Diagnoses and Persons Living with HIV, District 3-1 (Cobb-Douglas), Georgia, 2017

Total Gender Identity
Male Female Transgender Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race Asian/Native Hawaiian/Pacific Islander Multiple races
Age Group at Diagnosis (Years)
<13 13-19 20-29 30-39 40-49 50-59 60+
Transmission Category (Unadjusted)
Male-to-male sexual contact (MSM) Injection drug use (IDU) MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown
Transmission Category (Adjusted)
MSM IDU MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3

HIV Diagnoses

PLWH as of 12/31/2017

N

%

N

%

200

100

4,011

100

156

78.0

3,034

75.6

42

21.0

933

23.3

<5

--

38

0.8

129

64.5

2,483

61.9

46

23.0

909

22.7

17

8.5

361

9.0

<5

--

13

0.3

6

3.0

197

4.9

0

0.0

7

0.2

8

4.0

23

0.6

64

32.0

532

13.3

58

29.0

939

23.4

35

17.5

1,014

25.3

27

13.5

1,058

26.4

8

4.0

437

10.9

120

60.0

2,045

51.0

<5

--

154

3.8

<5

--

133

3.3

44

22.0

682

17.0

0

0.0

35

0.9

0

0.0

7

0.2

32

16.0

955

23.8

137

68.3

2,546

63.5

5

2.5

220

5.5

<5

--

163

4.1

56

28.0

990

24.7

0

0.0

35

0.9

0

0.0

7

0.2

* Percentages may not add up to 100% due to rounding 1. Includes Asian, Pacific Islander, Native Hawaiian, American Indian, Alaska Native, Multiple races 2. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 3. Includes perinatal exposure, hemophilia, blood transfusion.4. Perinatal/other pediatric: cases born to HIV-infected mother, and cases <13 with missing risk. 5. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding

2017 Georgia HIV Surveillance Summary

Page 21

Table 13. HIV Diagnoses and Persons Living with HIV, District 3-2 (Fulton), Georgia, 2017

Total Gender Identity
Male Female Transgender
Race/Ethnicity
Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races
Age Group at Diagnosis (Years)
<13 13-19 20-29 30-39 40-49 50-59 60+
Transmission Category (Unadjusted)
Male-to-male sexual contact (MSM) Injection drug use (IDU) MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown
Transmission Category (Adjusted)5
MSM IDU MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3

HIV Diagnoses

N

%

651

100

PLWH as of 12/31/2017

N

%

16,770

100

540

82.9

13,957

83.2

101

15.5

2,609

15.6

8

1.2

181

1.0

490

75.3

12,043

71.8

89

13.7

2,940

17.5

38

5.8

820

4.9

<5

--

11

0.1

5

0.8

56

0.3

15

2.3

670

4.0

0

0.0

10

0.1

25

3.8

48

0.3

276

42.4

2,048

12.2

174

26.7

3,876

23.1

84

12.9

4,011

23.9

62

9.5

4,597

27.4

30

4.6

2,174

13.0

428

65.7

9,933

59.2

9

1.4

702

4.2

<5

--

710

4.2

108

16.6

1,911

11.4

0

0.0

90

0.5

0

0.0

10

0.0

102

15.7

3,414

20.4

480

73.8

11,821

70.5

13

1.9

933

5.6

6

0.9

825

4.9

139

21.4

2,856

17.0

0

0.0

90

0.5

0

0.0

10

0.0

* Percentages may not add up to 100% due to rounding 1. Includes American Indian, Alaska Native, Multiple races 2. Heterosexual contact:

Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only),

person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 3. Includes perinatal exposure, hemophilia, blood transfusion.4. Perinatal/other pediatric: cases born to HIV-infected mother, and cases <13 with

missing risk. 5. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to

rounding

2017 Georgia HIV Surveillance Summary

Page 22

Table 14. HIV Diagnoses and Persons Living with HIV, District 3-3 (Clayton), Georgia, 2017

Total Gender Identity
Male Female Transgender Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races
Age Group at Diagnosis (Years)
<13 13-19 20-29 30-39 40-49 50-59 60+
Transmission Category (Unadjusted)
Male-to-male sexual contact (MSM) Injection drug use (IDU) MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown
Transmission Category (Adjusted)5
MSM IDU MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3

HIV Diagnoses

N

%

146

100

PLWH as of 12/31/2017

N

%

2,708

100

118

80.8

1,954

72.2

26

17.8

718

26.5

<5

--

36

1.1

127

87.0

2,240

82.7

5

3.4

133

4.9

9

6.2

180

6.6

<5

--

<5

--

<5

--

19

0.7

<5

--

107

4.0

0

0.0

7

0.3

9

6.2

22

0.8

73

50.0

488

18.0

31

21.2

637

23.5

17

11.6

610

22.5

15

10.3

685

25.3

<5

--

259

9.6

99

67.8

1,326

49.0

<5

--

101

3.7

<5

--

69

2.5

22

15.1

485

17.9

0

0.0

27

1.0

0

0.0

7

0.3

23

15.8

693

25.6

105

71.8

1,631

60.2

<5

--

152

5.6

<5

--

86

3.2

36

24.3

781

28.8

0

0.0

27

1.0

0

0.0

7

0.3

* Percentages may not add up to 100% due to rounding 1. Includes American Indian, Alaska Native, Multiple races 2. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 3. Includes perinatal exposure, hemophilia, blood transfusion.4. Perinatal/other pediatric: cases born to HIV-infected mother, and cases <13 with missing risk. 5. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding

2017 Georgia HIV Surveillance Summary

Page 23

Table 15. HIV Diagnoses and Persons Living with HIV, District 3-4 (East Metro), Georgia, 2017

Total Gender Identity
Male Female Transgender Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races
Age Group at Diagnosis (Years)
<13 13-19 20-29 30-39 40-49 50-59 60+
Transmission Category (Unadjusted)
Male-to-male sexual contact (MSM) Injection drug use (IDU) MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown
Transmission Category (Adjusted)5
MSM IDU MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3

HIV Diagnoses

N

%

218

100

PLWH as of 12/31/2017

N

%

4,091

100

167

76.6

2,932

71.7

47

21.6

1,113

27.2

<5

--

39

1.0

135

61.9

2,489

60.8

27

12.4

752

18.4

37

17.0

537

13.1

0

0.0

<5

--

10

4.6

62

1.5

<5

--

165

4.0

0

0.0

6

0.1

16

7.3

28

0.7

83

38.1

544

13.3

49

22.5

891

21.8

39

17.9

1,072

26.2

28

12.8

1,093

26.7

<5

--

457

11.2

109

50.0

1,904

46.5

5

2.3

125

3.1

0

0.0

100

2.4

25

11.5

701

17.1

0

0.0

54

1.3

0

0.0

6

0.1

79

36.2

1,201

29.4

143

65.7

2,443

59.7

9

4.2

207

5.1

<5

--

130

3.2

58

26.8

1,166

28.5

0

0.0

54

1.3

0

0.0

6

0.1

* Percentages may not add up to 100% due to rounding 1. Includes American Indian, Alaska Native, Multiple races 2. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 3. Includes perinatal exposure, hemophilia, blood transfusion.4. Perinatal/other pediatric: cases born to HIV-infected mother, and cases <13 with missing risk. 5. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding

2017 Georgia HIV Surveillance Summary

Page 24

Table 16. HIV Diagnoses and Persons Living with HIV, District 3-5 (DeKalb), Georgia, 2017

Total Gender Identity
Male Female Transgender Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races
Age Group at Diagnosis (Years)
<13 13-19 20-29 30-39 40-49 50-59 Unknown
Transmission Category (Unadjusted)
Male-to-male sexual contact (MSM) Injection drug use (IDU) MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown
Transmission Category (Adjusted)5
MSM IDU MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3

HIV Diagnoses

N

%

374

100

PLWH as of 12/31/2017

N

%

9,926

100

297

79.4

7,920

79.8

75

20.1

1,894

19.1

<5

--

101

1.0

296

79.1

7,093

71.5

35

9.4

1,688

17.0

27

7.2

612

6.2

0

0.0

<5

--

<5

--

69

0.7

7

1.9

345

3.5

0

0.0

13

0.1

20

5.3

47

0.5

152

40.6

1,226

12.4

102

27.3

2,223

22.4

46

12.3

2,346

23.6

40

10.7

2,809

28.3

0

0.0

<5

--

231

61.8

5,623

56.6

<5

--

298

3.0

5

1.3

287

2.9

60

16.0

1,308

13.2

0

0.0

79

0.8

0

0.0

13

0.1

75

20.1

2,318

23.4

259

69.4

6,833

68.8

6

1.7

469

4.7

7

1.8

364

3.7

97

25.8

2,052

20.7

0

0.0

79

0.8

0

0.0

13

0.1

* Percentages may not add up to 100% due to rounding 1. Includes American Indian, Alaska Native, Multiple races 2. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 3. Includes perinatal exposure, hemophilia, blood transfusion.4. Perinatal/other pediatric: cases born to HIV-infected mother, and cases <13 with missing risk. 5. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding

2017 Georgia HIV Surveillance Summary

Page 25

Table 17. HIV Diagnoses and Persons Living with HIV, District 4 (LaGrange), Georgia, 2017

Total Gender Identity
Male Female Transgender Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races
Age Group at Diagnosis (Years)
<13 13-19 20-29 30-39 40-49 50-59 60+
Transmission Category (Unadjusted)
Male-to-male sexual contact (MSM) Injection drug use (IDU) MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown
Transmission Category (Adjusted)5
MSM IDU MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3

HIV Diagnoses

PLWH as of 12/31/2017

N

%

N

%

125

100

2,155

100

100

80.0

1,539

71.4

25

20.0

601

27.9

0

0.0

14

0.5

77

61.6

1,313

60.9

35

28.0

565

26.2

<5

--

130

6.0

0

0.0

<5

--

0

0.0

5

0.2

<5

--

109

5.1

<5

--

6

4.8

51

40.8

33

26.4

12

9.6

12

9.6

10

8.0

11

0.5

20

0.9

314

14.6

435

20.2

461

21.4

609

28.3

304

14.1

51

40.8

<5

--

26

20.8

0

0.0

<5

--

43

34.4

904

41.9

102

4.7

61

2.8

383

17.8

31

1.4

11

0.4

663

30.9

73

58.5

1,214

56.3

5

4.3

148

6.9

<5

--

81

3.7

39

31.0

642

29.8

0

0.0

31

1.4

<5

--

11

0.4

* Percentages may not add up to 100% due to rounding 1. Includes Asian, Pacific Islander, Native Hawaiian, American Indian, Alaska Native, Multiple races 2. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 3. Includes perinatal exposure, hemophilia, blood transfusion.4. Perinatal/other pediatric: cases born to HIV-infected mother, and cases <13 with missing risk. 5. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding

2017 Georgia HIV Surveillance Summary

Page 26

Table 18. HIV Diagnoses and Persons Living with HIV, District 5-1 (Dublin), Georgia, 2017

Total Gender Identity
Male Female Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race Asian/Native Hawaiian/Pacific Islander Multiple races
Age Group at Diagnosis (Years)
<13 13-19 20-29 30-39 40-49 50-59 60+
Transmission Category (Unadjusted)
Male-to-male sexual contact Injection drug use MSM-IDU Heterosexual contact Adult Other Unknown
Transmission Category (Adjusted)5
Male-to-male sexual contact Injection drug use MSM-IDU Heterosexual contact Adult Other

HIV Diagnoses

N

%

25

100

PLWH as of 12/31/2017

N

%

612

100

14

56.0

404

66.0

11

44.0

208

34.0

21

84.0

460

75.2

<5

--

83

13.6

<5

--

39

6.4

0

0.0

<5

--

0

0.0

23

3.8

0

0.0

0

0.0

<5

--

<5

--

5

20.0

52

8.5

10

40.0

103

16.8

<5

--

150

24.5

<5

--

203

33.2

<5

--

101

16.5

7

28.0

145

23.7

<5

--

43

7.0

0

0.0

16

2.6

12

48.0

139

22.7

0

0.0

<5

--

<5

--

266

43.5

9

35.6

265

43.4

<5

--

69

11.3

25

4.1

13

51.6

244

39.8

0

0.0

<5

--

* Percentages may not add up to 100% due to rounding 1. Includes Asian, Pacific Islander, Native Hawaiian, American Indian, Alaska Native, Multiple races 2. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 3. Includes perinatal exposure, hemophilia, blood transfusion.4. Perinatal/other pediatric: cases born to HIV-infected mother, and cases <13 with missing risk. 5. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding

2017 Georgia HIV Surveillance Summary

Page 27

Table 19. HIV Diagnoses and Persons Living with HIV, District 5-2 (Macon), Georgia, 2017

Total Gender Identity
Male Female Transgender Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races
Age Group at Diagnosis (Years)
<13 13-19 20-29 30-39 40-49 50-59 60+
Transmission Category (Unadjusted)
Male-to-male sexual contact (MSM) Injection drug use (IDU) MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown
Transmission Category (Adjusted)5
MSM IDU MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3

HIV Diagnoses

N

%

98

100

PLWH as of 12/31/2017

N

%

2,203

100

70

70.7

1477

67.0

28

28.3

714

32.4

0

0.0

9

0.3

78

78.8

1649

74.9

16

16.2

336

15.3

0

0.0

89

4.0

0

0.0

<5

--

0

0.0

<5

--

<5

--

100

4.5

<5

--

7

0.3

8

8.1

15

0.7

38

38.4

326

14.8

20

20.2

436

19.8

16

16.2

468

21.2

12

12.1

616

28.0

<5

--

335

15.2

48

48.5

803

36.5

<5

--

92

4.2

54

2.5

30

30.3

442

20.1

<5

--

28

1.3

<5

--

7

0.3

17

17.2

777

35.3

57

57.4

1116

50.7

<5

--

166

7.5

0

0.0

76

3.5

35

34.9

787

35.7

<5

--

28

1.3

<5

--

7

0.3

* Percentages may not add up to 100% due to rounding 1. Includes Asian, Pacific Islander, Native Hawaiian, American Indian, Alaska Native, Multiple races 2. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 3. Includes perinatal exposure, hemophilia, blood transfusion.4. Perinatal/other pediatric: cases born to HIV-infected mother, and cases <13 with missing risk. 5. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding

2017 Georgia HIV Surveillance Summary

Page 28

Table 20. HIV Diagnoses and Persons Living with HIV, District 6 (Augusta), Georgia, 2017

Total Gender Identity
Male Female Transgender Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races Unknown
Age Group at Diagnosis (Years)
<13 13-19 20-29 30-39 40-49 50-59 60+
Transmission Category (Unadjusted)
Male-to-male sexual contact Injection drug use MSM-IDU Heterosexual contact Adult Other Perinatal/other pediatric
Transmission Category (Adjusted)5
Male-to-male sexual contact Injection drug use MSM-IDU Heterosexual contact Adult Other Perinatal/other pediatric Unknown

HIV Diagnoses

N

%

PLWH as of 12/31/2017

N

%

67

73.6

1,511

66.9

24

26.4

737

32.7

0

9

0.4

72

79.1

1,716

76.0

11

12.1

381

16.9

5

5.5

73

3.2

0

<5

<5

<5

<5

66

2.9

<5

17

0.8

0

5

5.5

45

49.5

19

20.9

5

5.5

9

9.9

8

8.8

6

0.3

49

2.2

284

12.6

373

16.5

433

19.2

692

30.7

420

18.6

47

51.6

0

<5

28

30.8

0

0

835

37.0

167

7.4

81

3.6

442

19.6

73

3.2

6

0.3

56

61.9

1,057

46.8

<5

241

10.7

<5

95

4.2

31

33.6

768

34.0

0

73

3.2

0

6

0.3

<5

17

0.8

* Percentages may not add up to 100% due to rounding 1. Includes Asian, Pacific Islander, Native Hawaiian, American Indian, Alaska Native, Multiple races 2. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 3. Includes perinatal exposure, hemophilia, blood transfusion.4. Perinatal/other pediatric: cases born to HIV-infected mother, and cases <13 with missing risk. 5. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding

2017 Georgia HIV Surveillance Summary

Page 29

Table 21. HIV Diagnoses and Persons Living with HIV, District 7 (Columbus), Georgia, 2017

Total Gender Identity
Male

HIV Diagnoses

N

%

PLWH as of 12/31/2017

N

%

77

64.7

1,183

65.5

Female Transgender

42

35.3

609

33.7

0

13

0.7

Race/Ethnicity Black/Non Hispanic

95

79.8

1,360

75.3

White/Non Hispanic Hispanic/Latino, Any Race

11

9.2

232

12.8

8

6.7

82

4.5

American Indian/Alaska Native

0

Asian/Native Hawaiian/Pacific Islander

0

<5

0.1

<5

0.2

Multiple races Unknown

<5

2.5

73

4.0

<5

1.7

54

3.0

Age Group at Diagnosis (Years)
<13 13-19

<5

1.7

7

0.4

5

4.2

13

0.7

20-29 30-39

39

32.8

228

12.6

27

22.7

352

19.5

40-49 50-59

25

21.0

433

24.0

12

10.1

491

27.2

60+

9

7.6

282

15.6

Transmission Category (Unadjusted)
Male-to-male sexual contact (MSM) Injection drug use (IDU)

37

31.1

568

31.5

<5

1.7

95

5.3

MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown
Transmission Category (Adjusted)5
MSM IDU MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown

38

2.1

33

27.7

434

24.0

0

18

1.0

<5

1.7

7

0.4

45

37.8

646

35.8

53

44.8

815

45.1

5

3.8

144

8.0

<5

0.6

52

2.9

57

47.5

715

39.6

0

18

1.0

<5

1.7

7

0.4

<5

1.7

54

3.0

* Percentages may not add up to 100% due to rounding 1. Includes Asian, Pacific Islander, Native Hawaiian, American Indian, Alaska Native, Multiple races 2. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 3. Includes perinatal exposure, hemophilia, blood transfusion.4. Perinatal/other pediatric: cases born to HIV-infected mother, and cases <13 with missing risk. 5. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding

2017 Georgia HIV Surveillance Summary

Page 30

Table 22. HIV Diagnoses and Persons Living with HIV, District 8-1 (Valdosta), Georgia, 2017

Total Gender Identity
Male Female Transgender Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race Asian/Native Hawaiian/Pacific Islander Multiple races Unknown
Age Group at Diagnosis (Years)
<13 13-19 20-29 30-39 40-49 50-59 60+
Transmission Category (Unadjusted)
Male-to-male sexual contact (MSM) Injection drug use (IDU) MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown
Transmission Category (Adjusted)5
MSM IDU MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown

HIV Diagnoses

PLWH as of 12/31/2017

N

%

N

%

42

61.8

26

38.2

0

50

73.5

7

10.3

5

7.4

<5

5

7.4

0

0

5

7.4

19

27.9

18

26.5

14

20.6

7

10.3

5

7.4

20

29.4

<5

<5

27

39.7

0

0

17

25.0

29

41.9

<5

<5

35

50.9

0

0

0

687

59.7

458

39.8

5

0.4

794

69.0

202

17.6

89

7.7

<5

56

4.9

9

0.8

<5

9

0.8

132

11.5

223

19.4

284

24.7

316

27.5

186

16.2

321

27.9

60

5.2

33

2.9

422

36.7

9

0.8

<5

305

26.5

430

37.3

84

7.3

40

3.4

578

50.2

9

0.8

<5

9

0.8

* Percentages may not add up to 100% due to rounding 1. Includes Asian, Pacific Islander, Native Hawaiian, American Indian, Alaska Native, Multiple races 2. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 3. Includes perinatal exposure, hemophilia, blood transfusion.4. Perinatal/other pediatric: cases born to HIV-infected mother, and cases <13 with missing risk. 5. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding

2017 Georgia HIV Surveillance Summary

Page 31

Table 23. HIV Diagnoses and Persons Living with HIV, District 8-2 (Albany), Georgia, 2017

HIV Diagnoses

PLWH as of 12/31/2017

Total Gender Identity
Male

N

%

N

%

56

64.4

1,092

61.4

Female

31

35.6

678

38.1

Transgender

0

9

0.5

Race/Ethnicity

Black/Non Hispanic

75

86.2

1,449

81.5

White/Non Hispanic

7

8.0

178

10.0

Hispanic/Latino, Any Race

<5

68

3.8

American Indian/Alaska Native

0

<5

Asian/Native Hawaiian/Pacific Islander

0

<5

Multiple races

<5

70

3.9

Unknown

0

12

0.7

Age Group at Diagnosis (Years)

<13

<5

7

0.4

13-19

5

5.7

21

1.2

20-29

33

37.9

254

14.3

30-39

20

23.0

355

20.0

40-49

9

10.3

379

21.3

50-59

10

11.5

482

27.1

60+

9

10.3

280

15.7

Transmission Category (Unadjusted)
Male-to-male sexual contact (MSM)

30

34.5

575

32.3

Injection drug use (IDU)

<5

66

3.7

MSM-IDU

0

30

1.7

Heterosexual contact1

28

32.2

411

23.1

Adult Other2

0

23

1.3

Perinatal/other pediatric3

<5

7

0.4

Unknown

27

31.0

667

37.5

Transmission Category (Adjusted)5
MSM

40

45.4

808

45.4

IDU

<5

125

7.1

MSM-IDU

0

0.2

43

2.4

Heterosexual contact1

44

50.6

760

42.7

Adult Other2

0

23

1.3

Perinatal/other pediatric3

<5

7

0.4

*UPnekrncoewntnages may not add up to 100% due to rounding 1. Includes Asian, Pa0cific Islander, Native Hawaiian, Ameri1ca2n Indian, Alaska Na0t.i7ve, Multiple races 2. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 3. Includes perinatal exposure, hemophilia, blood transfusion.4. Perinatal/other pediatric: cases born to HIV-infected mother, and cases <13 with missing risk. 5. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding

2017 Georgia HIV Surveillance Summary

Page 32

Table 24. HIV Diagnoses and Persons Living with HIV, District 9-1 (Savannah), Georgia, 2017

Total Gender Identity
Male Female Transgender Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race Asian/Native Hawaiian/Pacific Islander Multiple races Unknown
Age Group at Diagnosis (Years)
<13 13-19 20-29 30-39 40-49 50-59 60+
Transmission Category (Unadjusted)
Male-to-male sexual contact (MSM) Injection drug use (IDU) MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown
Transmission Category (Adjusted)5
MSM IDU MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown

HIV Diagnoses

PLWH as of 12/31/2017

N

%

N

%

100

75.2

1,867

67.7

32

24.1

879

31.9

<5

8

0.3

81

60.9

1,810

65.7

36

27.1

600

21.8

6

4.5

175

6.4

<5

8

0.3

6

4.5

131

4.8

<5

32

1.2

<5

7

0.3

7

5.3

12

0.4

51

38.3

359

13.0

30

22.6

511

18.5

19

14.3

555

20.1

18

13.5

823

29.9

7

5.3

488

17.7

70

52.6

994

36.1

<5

168

6.1

56

2.0

25

18.8

487

17.7

0

29

1.1

<5

7

0.2

36

27.8

1,015

36.9

85

63.7

1,398

50.7

<5

257

9.3

0

0.3

81

2.9

42

31.7

952

34.5

0

29

1.1

<5

7

0.2

<5

32

1.2

* Percentages may not add up to 100% due to rounding 1. Includes Asian, Pacific Islander, Native Hawaiian, American Indian, Alaska Native, Multiple races 2. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 3. Includes perinatal exposure, hemophilia, blood transfusion.4. Perinatal/other pediatric: cases born to HIV-infected mother, and cases <13 with missing risk. 5. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding

2017 Georgia HIV Surveillance Summary

Page 33

Table 25. HIV Diagnoses and Persons Living with HIV, District 9-2 (Waycross), Georgia, 2017

Total Gender Identity
Male Female Transgender Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race Multiple races Unknown
Age Group at Diagnosis (Years)
<13 13-19 20-29 30-39 40-49 50-59 60+
Transmission Category (Unadjusted)
Male-to-male sexual contact (MSM) Injection drug use (IDU) MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown
Transmission Category (Adjusted)5
MSM IDU MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown

HIV Diagnoses N

PLWH as of 12/31/2017

%

N

%

37

82.2

789

65.0

8

17.8

420

34.6

0

<5

26

57.8

775

63.9

9

20.0

259

21.4

7

15.6

88

7.3

<5

67

5.5

<5

24

2.0

<5

<5

0.1

<5

<5

0.2

11

24.4

149

12.3

12

26.7

223

18.4

9

20.0

286

23.6

6

13.3

355

29.3

<5

195

16.1

16

35.6

367

30.3

<5

65

5.4

<5

35

2.9

5

11.1

286

23.6

0

12

1.0

<5

<5

17

40.0

447

36.9

25

54.9

530

43.7

4

9.1

107

8.8

3

7.1

45

3.7

11

24.4

494

40.8

0

12

1.0

<5

<5

<5

24

2.0

* Percentages may not add up to 100% due to rounding 1. Includes Asian, Pacific Islander, Native Hawaiian, American Indian, Alaska Native, Multiple races 2. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 3. Includes perinatal exposure, hemophilia, blood transfusion.4. Perinatal/other pediatric: cases born to HIV-infected mother, and cases <13 with missing risk. 5. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding

2017 Georgia HIV Surveillance Summary

Page 34

Table 26. HIV Diagnoses and Persons Living with HIV, District 10 (Athens), Georgia, 2017

Total Gender Identity
Male Female Transgender Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race Asian/Native Hawaiian/Pacific Islander Multiple races Unknown
Age Group at Diagnosis (Years)
<13 13-19 20-29 30-39 40-49 50-59 60+
Transmission Category (Unadjusted)
Male-to-male sexual contact (MSM) Injection drug use (IDU) MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown
Transmission Category (Adjusted)5
MSM IDU MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown

HIV Diagnoses

N

%

PLWH as of 12/31/2017

N

%

39

72.2

666

66.1

13

24.1

324

32.1

<5

17

1.6

32

59.3

556

55.2

17

31.5

324

32.1

5

9.3

74

7.3

0

5

0.5

0

41

4.1

0

8

0.8

0

<5

<5

12

1.2

17

31.5

113

11.2

12

22.2

219

21.7

13

24.1

245

24.3

5

9.3

261

25.9

<5

153

15.2

29

53.7

383

38.0

<5

58

5.8

<5

36

3.6

14

25.9

214

21.2

0

14

1.4

0

4

0.4

7

13.0

299

29.7

35

64.6

508

50.4

<5

82

8.2

<5

43

4.2

15

27.2

349

34.6

0

14

1.4

0

<5

0

8

0.8

* Percentages may not add up to 100% due to rounding 1. Includes Asian, Pacific Islander, Native Hawaiian, American Indian, Alaska Native, Multiple races 2. Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 3. Includes perinatal exposure, hemophilia, blood transfusion.4. Perinatal/other pediatric: cases born to HIV-infected mother, and cases <13 with missing risk. 5. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding

2017 Georgia HIV Surveillance Summary

Page 35

HIV Diagnoses and Persons Living with HIV, Atlanta MSA
Table 27. HIV Diagnoses and Persons Living with HIV, Atlanta Metropolitan Statistical Area1, Georgia, 2017

Total Gender Identity
Male Female Transgender Race/Ethnicity Black/Non Hispanic White/Non Hispanic Hispanic/Latino, Any Race American Indian/Alaska Native Asian/Native Hawaiian/Pacific Islander Multiple races
Age Group at Diagnosis (Years)
<13 13-19 20-29 30-39 40-49 50-59 60+
Transmission Category (Unadjusted)
Male-to-male sexual contact (MSM) Injection drug use (IDU) MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3 Unknown
Transmission Category (Adjusted)5
MSM IDU MSM-IDU Heterosexual contact1 Adult Other2 Perinatal/other pediatric3

HIV Diagnoses

PLWH as of 12/31/2017

N

%

N

%

1,427

80.2

32,271

78.8

331

18.6

8,215

20.1

18

1.0

411

0.9

1,276

71.7

28,077

68.6

265

14.9

7,625

18.6

141

7.9

2,771

6.8

<5

--

22

0.1

23

1.3

236

0.6

37

2.1

1,648

4.0

<5

57

0.1

88

4.9

202

0.5

717

40.3

5,265

12.9

463

26.0

9,246

22.6

248

13.9

9,858

24.1

193

10.8

11,227

27.4

69

3.9

5,081

12.4

1,074

60.4

22,263

54.4

27

1.5

1,551

3.8

14

0.8

1,414

3.5

293

16.5

5,682

13.9

0

0.0

337

0.8

<5

--

48

0.1

370

20.8

9,651

23.6

1,238

69.6

27,208

66.4

45

2.5

2,224

5.4

20

1.1

1,718

4.2

441

24.8

8,830

21.6

0

0.0

337

0.8

<5

--

57

0.1

*Percents may not add up to 100 due to rounding 1.Barrow, Bartow, Butts, Carroll, Cherokee, Clayton, Cobb, Coweta, Dawson, DeKalb, Douglas, Fayette, Forsyth, Fulton, Gwinnett, Haralson, Heard, Henry, Jasper, Lamar, Meriwether, Morgan, Newton, Paulding, Pickens, Pike, Rockdale, Spalding, Walton 2. Includes American Indian, Alaska Native, Multiple races 3.Heterosexual contact: Defined as sexual contact with someone of the opposite sex with known risk such as injection drug use, bisexual male (applies to females only), person with hemophilia/coagulation disorder, transfusion recipient with HIV documentation, and or person with AIDS or documented HIV. 4. Includes perinatal exposure, hemophilia, blood transfusion.5. Perinatal/other pediatric: cases born to HIV-infected mother, and cases <13 with missing risk. 6. Adjusted for missing risk using multiple imputation methods. Adjusted subtotals may be different from unadjusted subtotals due to rounding

2017 Georgia HIV Surveillance Summary

Page 36

Late Diagnoses by Public Health District and Atlanta MSA
Table 28. Late diagnoses by Public Health District and for Atlanta Metropolitan Statistical Area, Georgia, 2017

Total
1-1 Northwest (Rome) 1-2 North Georgia (Dalton) 2 North (Gainesville) 3-1 Cobb-Douglas 3-2 Fulton 3-3 Clayton (Jonesboro) 3-4 East Metro (Lawrenceville) 3-5 DeKalb 4 LaGrange 5-1 South Central (Dublin) 5-2 North Central (Macon) 6 East Central (Augusta) 7 West Central (Columbus) 8-1 South (Valdosta) 8-2 Southwest (Albany) 9-1 Coastal (Savannah) 9-2 Southeast (Waycross) 10 Northeast (Athens) Unknown Health District

HIV Diagnoses
N
51 28 40 200 651 146 218 374 125 25 99 91 119 68 87 133 45 54 143

Late HIV Diagnoses Stage 3 [AIDS] within 12 months

N

row %

16

31.4

9

32.1

6

15.0

57

28.5

113

17.4

28

19.2

53

24.3

79

21.1

26

20.8

9

36.0

29

29.3

17

18.7

27

22.7

23

33.8

33

37.9

31

23.3

8

17.8

15

27.8

33

23.1

1.Barrow, Bartow, Butts, Carroll, Cherokee, Clayton, Cobb, Coweta, Dawson, DeKalb, Douglas, Fayette, Forsyth, Fulton, Gwinnett, Haralson, Heard, Henry, Jasper, Lamar, Meriwether, Morgan, Newton, Paulding, Pickens, Pike, Rockdale, Spalding, Walton

2017 Georgia HIV Surveillance Summary

Page 37

Public Health District and County Rates

Table 29. HIV diagnoses and persons living with HIV (PLWH): Public Health District and County number and rates per 100,000 population, Georgia 2017

HIV Diagnoses (all stages)

PLWH as of 12/31/2017

1-1 Northwest (Rome)
BARTOW CO. CATOOSA CO. CHATTOOGA DADE CO. FLOYD CO. GORDON CO. HARALSON CO. PAULDING CO. POLK CO. WALKER CO. 1-2 North Georgia (Dalton) CHEROKEE CO. FANNIN CO. GILMER CO. MURRAY CO. PICKENS CO. WHITFIELD CO. 2 North (Gainesville) BANKS CO. DAWSON CO. FORSYTH CO. FRANKLIN CO. HABERSHAM CO. HART CO. HALL CO. LUMPKIN CO. RABUN CO. STEPHENS CO. TOWNS CO. UNION CO. WHITE CO. 3-1 Cobb-Douglas COBB CO. DOUGLAS CO. 3-2 Fulton

N1
51 9
<5 <5 <5 12 <5 <5 12
6 5 28 22 0 0 0 <5 <5 40 0 <5 12 0 <5 <5 15 <5 0 <5 0 <5 <5 200 164 36 651

Rate/100,0002,3
7.6 -----
12.3 ---
0.1 ---
5.8 8.9 0.0 0.0 0.0
--5.7 0.0 -5.3 0.0 --7.5 -0.0 -0.0 --22.2 21.7 25.0 62.5

N1
1,089 200 66 60 13 247 59 33 282 56 72 677 365 36 43 46 44 143 829 17 25 190 41 63 47 281 32 18 47 6 32 30
4011 3,428
583 16,770

Rate/100,0002,3
163.2 190.4 99.2 242.2 79.8 253.0 103.3 112.8 176.9 133.1 104.4 141.2 147.4 142.2 140.2 115.6 139.3 136.6 117.9 91.2 102.5 83.3 179.7 141.4 182.2 141.0 97.3 108.4 181.5
136.4 101.9 445.9 453.6 405.2 1610.3

2017 Georgia HIV Surveillance Summary

Page 38

FULTON CO. 3-3 Clayton (Jonesboro) CLAYTON CO. 3-4 East Metro (Lawrenceville) GWINNETT CO. NEWTON CO. ROCKDALE CO. 3-5 DeKalb DEKALB CO. 4 LaGrange BUTTS CO. CARROLL CO. COWETA CO. FAYETTE CO. HEARD CO. HENRY CO. LAMAR CO. MERIWETHER CO. PIKE CO. SPALDING CO. TROUP CO. UPSON CO. 5-1 South Central (Dublin) BLECKLEY CO. DODGE CO. JOHNSON CO. LAURENS CO. MONTGOMERY CO. PULASKI CO. TELFAIR CO. TREUTLEN CO. WHEELER CO. WILCOX CO. 5-2 North Central (Macon) BALDWIN CO. BIBB CO. CRAWFORD CO. HANCOCK CO. HOUSTON CO. JASPER CO. JONES CO. MONROE CO. PEACH CO. PUTNAM CO. TWIGGS CO.

651

62.5

146

51.2

146

51.2

218

19.5

192

20.9

14

13.0

12

13.3

374

49.7

374

49.7

125

14.6

13

54.0

<5

--

14

9.8

15

13.3

0

0.0

40

17.7

5

--

0

0.0

<5

--

12

18.4

9

12.9

<5

--

25

16.6

<5

--

<5

--

<5

--

9

--

0

0.0

<5

--

6

--

0

0.0

0

0.0

0

0.0

99

18.8

8

--

51

33.4

<5

--

<5

--

25

16.3

0

0.0

0

0.0

0

0.0

5

--

0

0.0

0

0.0

2017 Georgia HIV Surveillance Summary

16,770 2,708 2,708 4,091 3,362 381 348 9,926 9,926 2,155 100 263 273 198 12 749 43 52 18 210 168 69 612 55 93 26 197 14 22 92 22 39 53 2,203 147 1,193 29 25 408 22 52 48 120 35 25

1610.3 949.7 949.7 365.7 365.3 352.5 385.3 1317.8 1317.8 252.3 415.6 223.2 190.8 175.9 102.3 331.7 231.2 247.0 98.8 313.6 240.7 264.0 406.9 428.7 448.6 265.6 416.2 155.0 196.4 575.4 326.4 490.4 602.3 417.3 327.4 780.4 235.9 292.0 265.8 157.5 182.6 177.0 442.8 161.1 305.8

Page 39

WASHINGTON CO. WILKINSON CO. 6 East Central (Augusta) BURKE CO. COLUMBIA CO. EMANUEL CO. GLASCOCK CO. JEFFERSON CO. JENKINS CO. LINCOLN CO. MCDUFFIE CO. RICHMOND CO. SCREVEN CO. TALIAFERRO CO. WARREN CO. WILKES CO. 7 West Central (Columbus) CHATTAHOOCHEE CO. CLAY CO. CRISP CO. DOOLY CO. HARRIS CO. MACON CO. MARION CO. MUSCOGEE CO. QUITMAN CO. RANDOLPH CO. SCHLEY CO. STEWART CO.4 SUMTER CO. TALBOT CO. TAYLOR CO. WEBSTER CO. 8-1 South (Valdosta) BEN HILL CO. BERRIEN CO. BROOKS CO. COOK CO. ECHOLS CO. IRWIN CO. LANIER CO. LOWNDES CO. TIFT CO. TURNER CO. 8-2 Southwest (Albany)

<5

--

<5

--

91

18.7

<5

--

13

8.6

5

--

0

0.0

<5

--

<5

--

0

0.0

<5

--

62

30.7

<5

--

0

0.0

0

0.0

<5

--

119

32.4

0

0.0

0

0.0

5

--

<4

--

4

--

0

0.0

0

0.0

84

43.3

0

0.0

<5

--

<5

--

9

--

9

--

<5

--

<5

--

0

0.0

68

26.5

0

0.0

0

0.0

<5

--

0

0.0

0

0.0

<5

--

<5

--

42

36.4

17

41.9

<5

--

87

25.1

2017 Georgia HIV Surveillance Summary

78 21 2,257 89 200 58
4 56 40 15 56 1,640 48
3 20 28 1,806 13 17 123 54 54 45 13 1,149 12 37
7 94 137 19 30
2 1,151
57 47 51 53
8 64 19 646 171 34 1,779

384.0 234.4 464.3 395.2 131.9 257.4
0.5 456.3 190.4 662.7 812.7 344.0
377.1 283.1 492.1 125.7 573.9 541.0 393.1 159.2 338.0 153.8 592.1 508.9 523.0
1570.6 459.0 304.0 368.5
448.1 335.4 245.0 327.2 306.8
680.1 182.3 559.4 421.2 427.1 513.0

Page 40

BAKER CO. CALHOUN CO. COLQUITT CO. DECATUR CO. DOUGHERTY CO. EARLY CO. GRADY CO. LEE CO. MILLER CO. MITCHELL CO. SEMINOLE CO. TERRELL CO. THOMAS CO. WORTH CO. 9-1 Coastal (Savannah) BRYAN CO. CAMDEN CO. CHATHAM CO. EFFINGHAM CO. GLYNN CO. LIBERTY CO. LONG CO. MCINTOSH CO. 9-2 Southeast (Waycross) APPLING CO. ATKINSON CO. BACON CO. BRANTLEY CO. BULLOCH CO. CANDLER CO. CHARLTON CO. CLINCH CO. COFFEE CO. EVANS CO. JEFF DAVIS CO. PIERCE CO. TATTNALL CO. TOOMBS CO. WARE CO. WAYNE CO. 10 Northeast (Athens) BARROW CO. CLARKE CO. ELBERT CO. GREENE CO.

0

0.0

0

0.0

8

--

<5

--

51

57.0

<5

--

<5

--

<5

--

0

0.0

<5

--

0

0.0

<5

--

10

22.3

<5

--

133

21.4

<5

--

<5

--

91

31.3

6

--

20

23.5

8

--

<5

--

<5

--

45

12.2

<5

--

0

0.0

<5

--

0

0.0

12

15.8

<5

--

7

--

<5

--

7

--

0

0.0

<5

--

<5

--

<5

--

<5

--

<5

--

<5

--

54

10.8

7

--

25

19.7

<5

--

<5

--

2017 Georgia HIV Surveillance Summary

5 33 215 137 809 25 69 62 21 93 23 42 168 77 2,756 42 101 1,890 77 354 222 19 51 1,213 31 11 43 23 285 32 44 28 127 44 33 25 98 97 186 106 1,008 137 424 34 32

511.2 469.1 512.8 903.9 242.8 278.0 210.4 359.7 417.2 277.4 481.2 375.2 375.0 444.2 113.3 190.4 650.6 128.4 415.1 361.6 99.9 603.6 328.3 167.4 131.9 379.9 122.8 374.3 296.4 346.0 416.2 295.3 408.4 219.6 129.5 386.8 359.3 518.5 355.5 200.7 173.3 333.7 177.9 185.2

Page 41

JACKSON CO. MADISON CO. MORGAN CO. OCONEE CO. OGLETHORPE CO. WALTON CO. Unknown Health District

5

--

0

0.0

<5

--

<5

--

<5

--

7

--

143

75 26 32 32 25 191 1,767

111.1 88.7 173.8 84.1 168.0 208.5

1. Cells <5 are not 2. Rates are not calculated when numerator is <12. 3. Persons residing in correctional facilities are included in this report and may inflate rates in certain geographic regions where there are large numbers of HIV-positive inmates. 4. Most cases associated with a federal detention center located in this county.

2017 Georgia HIV Surveillance Summary

Page 42

Distribution of General Population by Race/Ethnicity

Table 30. Distribution of the general population by race/ethnicity, Georgia 2017

Race/Ethnicity
White, Non-Hispanic Black, Non-Hispanic Hispanic/Latino, Any Race Asian, Non-Hispanic American Indian /Alaskan Native, Non-Hispanic Native Hawaiian/Pacific Islander, Non-Hispanic Multiracial/Other, Non-Hispanic
Total

Number (%)
5,507,334 (53) 3,267,577 (31) 1,005,959 (9) 430,841 (4) 23,711 (<1) 6,339 (<1) 181,618 (2)
10,429,379

Source: Georgia Online Analytical Statistical Information System (https://oasis.state.ga.us/oasis/webquery/qryPopulation.aspx)

2017 Georgia HIV Surveillance Summary

Page 43

HIV/AIDS RESOURCES:

Georgia Department of Public Health http://dph.georgia.gov/what-hiv-and-aids

Centers for Disease Control and Prevention http://www.cdc.gov/hiv/

AIDSVu http://aidsvu.org/

Reporting All health care providers diagnosing and/or providing care to a patient with HIV are required by Georgia law (O.C.G.A. 31-12-1) to report HIV infection using the HIV/AIDS Case Report Form. Case report forms should be completed within seven (7) days of diagnosing a patient with HIV and/or AIDS or within seven (7) days of assuming care of an HIV positive patient who is new to the provider, regardless of whether the patient has previously received care elsewhere. Adult and Pediatric case report forms are available at https://dph.georgia.gov/hivaids-case-reporting For more questions on HIV case reporting in Georgia please contact the HIV Surveillance Coordinator at 1800-827-9769

2017 Georgia HIV Surveillance Summary

Page 44